These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 18212743)

  • 1. Genomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancer.
    Kwei KA; Kim YH; Girard L; Kao J; Pacyna-Gengelbach M; Salari K; Lee J; Choi YL; Sato M; Wang P; Hernandez-Boussard T; Gazdar AF; Petersen I; Minna JD; Pollack JR
    Oncogene; 2008 Jun; 27(25):3635-40. PubMed ID: 18212743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hepatocyte nuclear factor 3 alpha gene, HNF3alpha (FOXA1), on chromosome band 14q13 is amplified and overexpressed in esophageal and lung adenocarcinomas.
    Lin L; Miller CT; Contreras JI; Prescott MS; Dagenais SL; Wu R; Yee J; Orringer MB; Misek DE; Hanash SM; Glover TW; Beer DG
    Cancer Res; 2002 Sep; 62(18):5273-9. PubMed ID: 12234996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic and functional analysis identifies CRKL as an oncogene amplified in lung cancer.
    Kim YH; Kwei KA; Girard L; Salari K; Kao J; Pacyna-Gengelbach M; Wang P; Hernandez-Boussard T; Gazdar AF; Petersen I; Minna JD; Pollack JR
    Oncogene; 2010 Mar; 29(10):1421-30. PubMed ID: 19966867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid transcription factor-1-regulated microRNA-532-5p targets KRAS and MKL2 oncogenes and induces apoptosis in lung adenocarcinoma cells.
    Griesing S; Kajino T; Tai MC; Liu Z; Nakatochi M; Shimada Y; Suzuki M; Takahashi T
    Cancer Sci; 2017 Jul; 108(7):1394-1404. PubMed ID: 28474808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterizing the cancer genome in lung adenocarcinoma.
    Weir BA; Woo MS; Getz G; Perner S; Ding L; Beroukhim R; Lin WM; Province MA; Kraja A; Johnson LA; Shah K; Sato M; Thomas RK; Barletta JA; Borecki IB; Broderick S; Chang AC; Chiang DY; Chirieac LR; Cho J; Fujii Y; Gazdar AF; Giordano T; Greulich H; Hanna M; Johnson BE; Kris MG; Lash A; Lin L; Lindeman N; Mardis ER; McPherson JD; Minna JD; Morgan MB; Nadel M; Orringer MB; Osborne JR; Ozenberger B; Ramos AH; Robinson J; Roth JA; Rusch V; Sasaki H; Shepherd F; Sougnez C; Spitz MR; Tsao MS; Twomey D; Verhaak RG; Weinstock GM; Wheeler DA; Winckler W; Yoshizawa A; Yu S; Zakowski MF; Zhang Q; Beer DG; Wistuba II; Watson MA; Garraway LA; Ladanyi M; Travis WD; Pao W; Rubin MA; Gabriel SB; Gibbs RA; Varmus HE; Wilson RK; Lander ES; Meyerson M
    Nature; 2007 Dec; 450(7171):893-8. PubMed ID: 17982442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative genomic analyses identify BRF2 as a novel lineage-specific oncogene in lung squamous cell carcinoma.
    Lockwood WW; Chari R; Coe BP; Thu KL; Garnis C; Malloff CA; Campbell J; Williams AC; Hwang D; Zhu CQ; Buys TP; Yee J; English JC; Macaulay C; Tsao MS; Gazdar AF; Minna JD; Lam S; Lam WL
    PLoS Med; 2010 Jul; 7(7):e1000315. PubMed ID: 20668658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of putative oncogenes in lung adenocarcinoma by a comprehensive functional genomic approach.
    Li R; Wang H; Bekele BN; Yin Z; Caraway NP; Katz RL; Stass SA; Jiang F
    Oncogene; 2006 Apr; 25(18):2628-35. PubMed ID: 16369491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of lung adenocarcinoma progression by Nkx2-1.
    Winslow MM; Dayton TL; Verhaak RG; Kim-Kiselak C; Snyder EL; Feldser DM; Hubbard DD; DuPage MJ; Whittaker CA; Hoersch S; Yoon S; Crowley D; Bronson RT; Chiang DY; Meyerson M; Jacks T
    Nature; 2011 May; 473(7345):101-4. PubMed ID: 21471965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid transcription factor-1 (TTF-1/Nkx2.1/TITF1) gene regulation in the lung.
    Boggaram V
    Clin Sci (Lond); 2009 Jan; 116(1):27-35. PubMed ID: 19037882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor tyrosine kinase-like orphan receptor 1, a target of NKX2-1/TTF-1 lineage-survival oncogene, inhibits apoptosis signal-regulating kinase 1-mediated pro-apoptotic signaling in lung adenocarcinoma.
    Ida L; Yamaguchi T; Yanagisawa K; Kajino T; Shimada Y; Suzuki M; Takahashi T
    Cancer Sci; 2016 Feb; 107(2):155-61. PubMed ID: 26661061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung cancer signatures in plasma based on proteome profiling of mouse tumor models.
    Taguchi A; Politi K; Pitteri SJ; Lockwood WW; Faça VM; Kelly-Spratt K; Wong CH; Zhang Q; Chin A; Park KS; Goodman G; Gazdar AF; Sage J; Dinulescu DM; Kucherlapati R; Depinho RA; Kemp CJ; Varmus HE; Hanash SM
    Cancer Cell; 2011 Sep; 20(3):289-99. PubMed ID: 21907921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide analyses of Nkx2-1 binding to transcriptional target genes uncover novel regulatory patterns conserved in lung development and tumors.
    Tagne JB; Gupta S; Gower AC; Shen SS; Varma S; Lakshminarayanan M; Cao Y; Spira A; Volkert TL; Ramirez MI
    PLoS One; 2012; 7(1):e29907. PubMed ID: 22242187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-365 regulates NKX2-1, a key mediator of lung cancer.
    Kang SM; Lee HJ; Cho JY
    Cancer Lett; 2013 Jul; 335(2):487-94. PubMed ID: 23507558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NKX2-1/TITF1/TTF-1-Induced ROR1 is required to sustain EGFR survival signaling in lung adenocarcinoma.
    Yamaguchi T; Yanagisawa K; Sugiyama R; Hosono Y; Shimada Y; Arima C; Kato S; Tomida S; Suzuki M; Osada H; Takahashi T
    Cancer Cell; 2012 Mar; 21(3):348-61. PubMed ID: 22439932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenic cooperation and coamplification of developmental transcription factor genes in lung cancer.
    Kendall J; Liu Q; Bakleh A; Krasnitz A; Nguyen KC; Lakshmi B; Gerald WL; Powers S; Mu D
    Proc Natl Acad Sci U S A; 2007 Oct; 104(42):16663-8. PubMed ID: 17925434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification.
    Kim YH; Girard L; Giacomini CP; Wang P; Hernandez-Boussard T; Tibshirani R; Minna JD; Pollack JR
    Oncogene; 2006 Jan; 25(1):130-8. PubMed ID: 16116477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disturbed expression of type 1 and type 2 iodothyronine deiodinase as well as titf1/nkx2-1 and pax-8 transcription factor genes in papillary thyroid cancer.
    Ambroziak M; Pachucki J; Stachlewska-Nasfeter E; Nauman J; Nauman A
    Thyroid; 2005 Oct; 15(10):1137-46. PubMed ID: 16279847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A transcriptional profiling study of CCAAT/enhancer binding protein targets identifies hepatocyte nuclear factor 3 beta as a novel tumor suppressor in lung cancer.
    Halmos B; Bassères DS; Monti S; D'Aló F; Dayaram T; Ferenczi K; Wouters BJ; Huettner CS; Golub TR; Tenen DG
    Cancer Res; 2004 Jun; 64(12):4137-47. PubMed ID: 15205324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amplification and overexpression of the dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 (DYRK2) gene in esophageal and lung adenocarcinomas.
    Miller CT; Aggarwal S; Lin TK; Dagenais SL; Contreras JI; Orringer MB; Glover TW; Beer DG; Lin L
    Cancer Res; 2003 Jul; 63(14):4136-43. PubMed ID: 12874018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic profiling identifies GATA6 as a candidate oncogene amplified in pancreatobiliary cancer.
    Kwei KA; Bashyam MD; Kao J; Ratheesh R; Reddy EC; Kim YH; Montgomery K; Giacomini CP; Choi YL; Chatterjee S; Karikari CA; Salari K; Wang P; Hernandez-Boussard T; Swarnalata G; van de Rijn M; Maitra A; Pollack JR
    PLoS Genet; 2008 May; 4(5):e1000081. PubMed ID: 18535672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.